Answer
Patients experiencing effects such as dizziness, vertigo, visual disturbances or fatigue after Depo-Medrone (methylprednisolone acetate) treatment should not drive or operate machinery; corticosteroids’ effects on these abilities have not been systematically evaluated.
Sources for this answer
- Depo-Medrone 40mg/ml Suspension for InjectionPfizer Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 30Document updated
Sources checked